Detalhe da pesquisa
1.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
Gastroenterology
; 162(2): 495-508, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34748774
2.
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 105-115.e14, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950748
3.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
Gastroenterology
; 158(3): 537-549.e10, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493397
4.
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
JAMA
; 326(1): 46-55, 2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081073
5.
Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study.
Clin Transl Gastroenterol
; 14(7): e00578, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881820
6.
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination.
Sci Transl Med
; 14(655): eabn3041, 2022 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35679357
7.
Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2).
Trials
; 22(1): 726, 2021 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674750
8.
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.
J Hematol Oncol
; 10(1): 73, 2017 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28327200
9.
Impaired collateral development in mature rats.
Am J Physiol Heart Circ Physiol
; 283(1): H146-55, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12063285
10.
Impaired collateral artery development in spontaneously hypertensive rats.
Microcirculation
; 9(5): 343-51, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12375172